Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析

◆英語タイトル:Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME3859FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Agilent Technologies Inc (A) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises liquid chromatography systems and components, gas chromatography systems and components, microarray solutions, clinical and diagnostic testing, and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, food and other industries. Agilent markets products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc Key Recent Developments

Mar 30,2021: Agilent awards Octagon Therapeutics with a Golden Ticket at LabCentral
Mar 09,2021: Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Mar 03,2021: Agilent Technologies agrees to acquire Resolution Bioscience for $695m
Feb 17,2021: Agilent reports first-quarter fiscal year 2021 financial results
Jan 26,2021: Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Agilent Technologies Inc – Key Facts
Agilent Technologies Inc – Key Employees
Agilent Technologies Inc – Key Employee Biographies
Agilent Technologies Inc – Major Products and Services
Agilent Technologies Inc – History
Agilent Technologies Inc – Company Statement
Agilent Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Agilent Technologies Inc – Business Description
Business Segment: Agilent CrossLab
Overview
Performance
Key Stats
Business Segment: Diagnostics and Genomics
Overview
Performance
Key Stats
Business Segment: Life Sciences and Applied Markets
Overview
Performance
Key Stats
Geographical Segment: China
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Agilent Technologies Inc – Corporate Strategy
Agilent Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
Agilent Technologies Inc – Strengths
Agilent Technologies Inc – Weaknesses
Agilent Technologies Inc – Opportunities
Agilent Technologies Inc – Threats
Agilent Technologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Agilent Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Agilent Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2021: Agilent awards Octagon Therapeutics with a Golden Ticket at LabCentral
Mar 09, 2021: Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Feb 17, 2021: Agilent reports first-quarter fiscal year 2021 financial results
Jan 26, 2021: Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
Jan 25, 2021: Agilent announces enhanced mass spectrometry and automation software solutions to support regulatory compliance guidelines
Jan 15, 2021: Agilent names Allison Ballmer Senior Vice President of Strategy and Corporate Development
Dec 14, 2020: Agilent receives multiple innovation awards
Dec 07, 2020: Agilent presents thought leader award to IIT Delhi scientist professor Anurag Rathore
Dec 03, 2020: Agilent announces Alissa Interpret selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis
Dec 02, 2020: Agilent announces new, innovative 7850 ICP-MS system
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Agilent Technologies Inc, Key Facts
Agilent Technologies Inc, Key Employees
Agilent Technologies Inc, Key Employee Biographies
Agilent Technologies Inc, Major Products and Services
Agilent Technologies Inc, History
Agilent Technologies Inc, Subsidiaries
Agilent Technologies Inc, Key Competitors
Agilent Technologies Inc, Ratios based on current share price
Agilent Technologies Inc, Annual Ratios
Agilent Technologies Inc, Annual Ratios (Cont...1)
Agilent Technologies Inc, Annual Ratios (Cont...2)
Agilent Technologies Inc, Interim Ratios
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Agilent Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Agilent Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • HighCom Global Security, Inc.:企業の戦略・SWOT・財務分析
    HighCom Global Security, Inc. - Strategy, SWOT and Corporate Finance Report Summary HighCom Global Security, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Agappe Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Agappe Diagnostics Ltd (Agappe) is an in-vitro diagnostic company that offers biochemistry products. The company offers biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; point of care, urinalysis and auxiliary products. Its biochemis …
  • The Wistar Institute-医療機器分野:企業M&A・提携分析
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training in cancer, infectious diseases, immunology and vaccine development. The institute conducts research on genes, gene expression, and DNA biology; cancer biology; translational resear …
  • Endurance Wind Power Inc.-エネルギー分野:企業M&A・提携分析
    Summary Endurance Wind Power Inc. (Endurance) designs, manufactures and markets wind turbines. It offers remote monitoring services through EnduranceRemote Interface Centre (ERIC) proprietary system which provides real-time performance data to check wind speed and monitor the turbine’s operational s …
  • Bio3 Research Srl-製薬・医療分野:企業M&A・提携分析
    Summary Bio3 Research Srl (Bio3 Research) is a biopharmaceutical company that undertakes the identification and development of therapeutic agents for diseases related to HMGB1 protein over-expression and HMGB1 biological properties. The company develops proprietary compounds with therapeutic potenti …
  • Citigroup Inc:企業の戦略・SWOT・財務情報
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Glory Ltd:企業の戦略・SWOT・財務分析
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Empire Energy Group Ltd (EEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • GulfMark Offshore Inc (GLF):石油・ガス:M&Aディール及び事業提携情報
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. The company owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas dri …
  • Energy Resources of Australia Ltd (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tarsa Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the …
  • Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • CoImmune Inc (ARGS):企業の財務・戦略的SWOT分析
    Summary CoImmune Inc(CoImmune) formerly known as Argos Therapeutics Inc, is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platfo …
  • LMI Aerospace, Inc.:企業の戦略的SWOT分析
    LMI Aerospace, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Sumitomo Mitsui Banking Corp:企業の戦略・SWOT・財務情報
    Sumitomo Mitsui Banking Corp - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Banking Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enamine Ltd (Enamine) is a provider of screening and drug discovery services. The company’s products include building blocks and intermediates, screening compounds, real database, compound libraries, fragment library, tangible building blocks, materials chemistry and scaffolds. It offers ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆